Voyager Therapeutics: 1Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $27.2 million in its first quarter.

The Cambridge, Massachusetts-based company said it had a loss of 81 cents per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.

The gene therapy company posted revenue of $5.2 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $3 million.

Voyager Therapeutics shares have more than doubled since the beginning of the year. The stock has risen 28% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR